Stability of nanosuspensions in drug delivery

被引:398
|
作者
Wang, Yancai [1 ,2 ]
Zheng, Ying [2 ]
Zhang, Ling [3 ]
Wang, Qiwei [4 ]
Zhang, Dianrui [4 ]
机构
[1] Shandong Polytech Univ, Sch Chem & Pharmaceut Engn, Jinan 250353, Peoples R China
[2] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Macao, Peoples R China
[3] Shandong Univ Finance & Econ, Jinan 250014, Peoples R China
[4] Shandong Univ, Coll Pharm, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanosuspensions; Stability; Stabilizers; Aggregation; Crystalline transformation; SOLID LIPID NANOPARTICLES; LONG-TERM STABILITY; TOP-DOWN; ANTITUMOR-ACTIVITY; PHARMACOKINETIC EVALUATION; ORIDONIN NANOSUSPENSION; PROCESS PARAMETERS; PARTICLE-SIZE; IN-VITRO; FORMULATION;
D O I
10.1016/j.jconrel.2013.08.006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nanosuspensions are nanosized colloidal dispersion systems that are stabilized by surfactants and or polymers. Because nanosizing results in the creation of new interfaces and in a positive Gibbs free energy change, nanosuspensions are thermodynamically unstable systems with a tendency toward agglomeration or crystal growth. Despite extensive research on nanosuspension technology, stability remains a limitation for pharmaceutical or industrial applications of nanosuspensions. Furthermore, the empirical relationship between stabilizer efficacy and nanosuspension stability has not been well characterized. This review focuses on the issue of nanosuspension stability in drug delivery to present the state of the art of nanosuspensions. Therefore, this review will discuss unstable suspensions, methods and guidelines for selecting and optimizing stabilizers, approaches for enhancing stability, and other factors that influence nanosuspension stability. This review could serve as a reference for the educated selection of a stabilizer for a specific drug candidate and the optimization of the operational parameters for inanosuspension formulation, rather than the currently practiced trial-and-error approach. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1126 / 1141
页数:16
相关论文
共 50 条
  • [1] The technology for improving stability of nanosuspensions in drug delivery
    Guan, Wenhao
    Ma, Yingying
    Ding, Shuaijie
    Liu, Yanchao
    Song, Zimin
    Liu, Xiang
    Tang, Lingling
    Wang, Yancai
    JOURNAL OF NANOPARTICLE RESEARCH, 2022, 24 (01)
  • [2] The technology for improving stability of nanosuspensions in drug delivery
    Wenhao Guan
    Yingying Ma
    Shuaijie Ding
    Yanchao Liu
    Zimin Song
    Xiang Liu
    Lingling Tang
    Yancai Wang
    Journal of Nanoparticle Research, 2022, 24
  • [3] Nanosuspensions in drug delivery
    Barrett E. Rabinow
    Nature Reviews Drug Discovery, 2004, 3 : 785 - 796
  • [4] Nanosuspensions in drug delivery
    Rabinow, BE
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) : 785 - 796
  • [5] Safety of nanosuspensions in drug delivery
    Wang, Lulu
    Du, Juan
    Zhou, Yuqi
    Wang, Yancai
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (02) : 455 - 469
  • [6] Nanosuspensions A versatile drug delivery platform
    Cavalli, Roberta
    Leone, Federica
    CHIMICA OGGI-CHEMISTRY TODAY, 2013, 31 (04) : 46 - 49
  • [7] Nanosuspensions: a promising drug delivery strategy
    Patravale, VB
    Date, AA
    Kulkarni, RM
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (07) : 827 - 840
  • [8] Emerging role of nanosuspensions in drug delivery systems
    Shery Jacob
    Anroop B. Nair
    Jigar Shah
    Biomaterials Research, 24
  • [9] NANOSUSPENSIONS - A PROMISING NOVEL DRUG DELIVERY SYSTEM
    Kumar, R. Santosh
    Kulkarni, Mangesh Pradeep
    Burela, Anjali
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (03): : 1478 - 1484
  • [10] Emerging role of nanosuspensions in drug delivery systems
    Jacob, Shery
    Nair, Anroop B.
    Shah, Jigar
    BIOMATERIALS RESEARCH, 2020, 24 (01)